DHS ordered to map biodetection gaps and plan upgrades
H.R. 706 — DHS Biodetection Improvement Act · Filed by Dale Strong (R-AL) · 1 cosponsor · Introduced Jan 23, 2025 · Passed chamber
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill directs the Department of Homeland Security to assess how it currently uses Department of Energy national laboratories for biodetection research, and to develop a strategy for coordinating with those labs to improve biodetection technologies—particularly for the BioWatch program that monitors for biological threats. DHS must report back to Congress within 180 days with a plan to acquire and deploy better biodetection equipment, evaluate performance, and work with state, local, tribal, and private partners on future biodetection programs.
Why we flagged it
The bill is fundamentally a directive for strategic assessment and coordination of biodetection capabilities across federal agencies and partners. It is a planning and accountability measure, not a substantive appropriation or regulatory change, focused on improving public biosecurity infrastructure.
What the text implies
- The bill's emphasis on 'periodic external evaluations' and 'contingency plans' suggests DHS may be acknowledging performance gaps in the existing BioWatch network, potentially signaling that current biodetection coverage is inadequate.
- Requirement to work with 'private sector' partners on biodetection programs may create opportunities for private companies to influence or capture biodetection technology standards and procurement, depending on how partnerships are structured.
The full analysis lists 3 implications of this text.
Who stands to gain
biodetection technology vendors and manufacturers; Department of Energy national laboratories (increased contract work); systems integrators and consultants specializing in biosecurity